Previous close | 3,541.00 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 3,541.00 - 3,541.00 |
52-week range | 2,671.39 - 4,012.00 |
Volume | |
Avg. volume | 3 |
Market cap | 573.295B |
Beta (5Y monthly) | 0.69 |
PE ratio (TTM) | 29.58 |
EPS (TTM) | 119.69 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | 36.03 (1.02%) |
Ex-dividend date | 08 May 2024 |
1y target est | N/A |
ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence of insomnia among adults in North America, Latin America, and the Caribbean, and a higher rate of depression in women with OSASAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the annual joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society. Held in H
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.